Surgery Partners annual ebitda
2013
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
Surgery Partners EBITDA Growth & History (SGRY)
Surgery Partners's calculated EBITDA was $565.5M for fiscal 2025.
View full Surgery Partners company overviewSurgery Partners annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $565.5M | $64.1M | +12.78% |
| 2024 | 2024-12-31 | $501.4M | $55.3M | +12.40% |
| 2023 | 2023-12-31 | $446.1M | −$13.9M | −3.02% |
| 2022 | 2022-12-31 | $460.0M | $59.0M | +14.71% |
| 2021 | 2021-12-31 | $401.0M | $123.2M | +44.35% |
| 2020 | 2020-12-31 | $277.8M | −$34.6M | −11.08% |
| 2019 | 2019-12-31 | $312.4M | $167.2M | +115.15% |
| 2018 | 2018-12-31 | $145.2M | — | — |
| 2016 | 2016-12-31 | $236.0M | $56.7M | +31.64% |
| 2015 | 2015-12-31 | $179.3M | $113.4M | +172.21% |
| 2014 | 2014-12-31 | $65.9M | −$4.0M | −5.75% |
| 2013 | 2013-12-31 | $69.9M | — | — |
Surgery Partners quarterly ebitda
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $141.4M | −$10.6M | −6.97% |
| Q1 2026 | 2026-03-31 | $104.3M | $6.1M | +6.21% |
| Q4 2025 | 2025-12-31 | $170.1M | $9.1M | +5.65% |
| Q3 2025 | 2025-09-30 | $145.2M | $34.1M | +30.69% |
| Q2 2025 | 2025-06-30 | $152.0M | $32.4M | +27.09% |
| Q1 2025 | 2025-03-31 | $98.2M | −$11.5M | −10.48% |
| Q4 2024 | 2024-12-31 | $161.0M | $28.5M | +21.51% |
| Q3 2024 | 2024-09-30 | $111.1M | −$400,000 | −0.36% |
| Q2 2024 | 2024-06-30 | $119.6M | −$2.4M | −1.97% |
| Q1 2024 | 2024-03-31 | $109.7M | $29.6M | +36.95% |
| Q4 2023 | 2023-12-31 | $132.5M | $8.7M | +7.03% |
| Q3 2023 | 2023-09-30 | $111.5M | $7.6M | +7.31% |
| Q2 2023 | 2023-06-30 | $122.0M | $17.5M | +16.75% |
| Q1 2023 | 2023-03-31 | $80.1M | −$47.7M | −37.32% |
| Q4 2022 | 2022-12-31 | $123.8M | −$13.7M | −9.96% |
| Q3 2022 | 2022-09-30 | $103.9M | $15.1M | +17.00% |
| Q2 2022 | 2022-06-30 | $104.5M | $19.8M | +23.38% |
| Q1 2022 | 2022-03-31 | $127.8M | $37.8M | +42.00% |
| Q4 2021 | 2021-12-31 | $137.5M | $15.7M | +12.89% |
| Q3 2021 | 2021-09-30 | $88.8M | $46.2M | +108.45% |
| Q2 2021 | 2021-06-30 | $84.7M | $16.6M | +24.38% |
| Q1 2021 | 2021-03-31 | $90.0M | $44.7M | +98.68% |
| Q4 2020 | 2020-12-31 | $121.8M | $29.8M | +32.39% |
| Q3 2020 | 2020-09-30 | $42.6M | −$34.8M | −44.96% |
| Q2 2020 | 2020-06-30 | $68.1M | −$6.5M | −8.71% |
| Q1 2020 | 2020-03-31 | $45.3M | −$23.1M | −33.77% |
| Q4 2019 | 2019-12-31 | $92.0M | $125.9M | — |
| Q3 2019 | 2019-09-30 | $77.4M | $15.4M | +24.84% |
| Q2 2019 | 2019-06-30 | $74.6M | $14.4M | +23.92% |
| Q1 2019 | 2019-03-31 | $68.4M | $11.5M | +20.21% |
| Q4 2018 | 2018-12-31 | −$33.9M | — | — |
| Q3 2018 | 2018-09-30 | $62.0M | — | — |
| Q2 2018 | 2018-06-30 | $60.2M | $11.0M | +22.47% |
| Q1 2018 | 2018-03-31 | $56.9M | $4.1M | +7.71% |
| Q2 2017 | 2017-06-30 | $49.2M | −$11.5M | −18.95% |
| Q1 2017 | 2017-03-31 | $52.8M | $9.0M | +20.48% |
| Q4 2016 | 2016-12-31 | $79.0M | $48.8M | +162.07% |
| Q3 2016 | 2016-09-30 | $52.6M | −$324,000 | −0.61% |
| Q2 2016 | 2016-06-30 | $60.6M | $11.2M | +22.61% |
| Q1 2016 | 2016-03-31 | $43.8M | −$3.0M | −6.33% |
| Q4 2015 | 2015-12-31 | $30.1M | — | — |
| Q3 2015 | 2015-09-30 | $52.9M | $30.4M | +135.17% |
| Q2 2015 | 2015-06-30 | $49.5M | — | — |
| Q1 2015 | 2015-03-31 | $46.8M | — | — |
| Q3 2014 | 2014-09-30 | $22.5M | — | — |
Surgery Partners ebitda trends
Over the last five fiscal years, Surgery Partners's ebitda increased from $277.8M to $565.5M, a change of $287.7M. The latest reported quarter, Q2 2026, shows $141.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Surgery Partners source filings ↗Community posts
Surgery Partners completes Idaho hospital sale for $797 million gross proceeds
Surgery Partners ($SGRY) completed the sale of its ownership interests in Idaho Falls Community Hospital and Mountain View Hospital to Intermountain Health. The company received approximately $797 million in gross proceeds and $587 million ...
